mito-extra® - medac GmbH
mito-extra® - medac GmbH
mito-extra® - medac GmbH
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
I<br />
K<br />
L<br />
Initialtherapie .................................... 20, 28, 30, 31, 34, 46, 48<br />
Implantationsmetastasen .................................................... 22<br />
Interferon ...................................................................... 46, 47<br />
Intermediate risk .............................. 19, 20, 21, 38, 43, 48, 50<br />
KLH .................................................................................... 47<br />
Katheter .................................................................. 3, 8, 9, 14<br />
Kathetersicherung ............................................................. 3, 8<br />
Langzeittherapie ........................................................... 32, 33<br />
M<br />
Metaanalyse .......................................... 26, 27, 36, 37, 43, 44<br />
Mitomycin-Reduktase ......................................................... 15<br />
Mutamycin .......................................................................... 17<br />
N<br />
Nebenwirkungen ...................................... 5, 18, 40, 44, 49, 51<br />
nekrotisierend ................................................................. 6, 27<br />
O<br />
Oberer Harntrakt ........................................................... 52, 53<br />
P<br />
R<br />
S<br />
Pasteur ............................................................................... 48<br />
pTa ........................................................ 32, 38, 39, 40, 46, 47<br />
pT1 ................................................................... 38, 39, 40, 46<br />
Plasmaspiegel ..................................................................... 18<br />
Plaques .............................................................................. 06<br />
Pharmakokinetik ........................................................... 18, 29<br />
Pollakisurie .......................................................................... 44<br />
Progression ................... 33, 40, 41, 43, 44, 48, 49, 50, 52, 53<br />
Reflux ........................................................................... 52, 53<br />
Rezidiventstehung ............................................................... 26<br />
RIVM ................................................................. 38, 39, 40, 47<br />
S-Phase .............................................................................. 15<br />
Spülflüssigkeit ..................................................................... 22<br />
55
Change language